Oramed Pharmaceuticals (ORMP) Return on Sales [ROS] (2016 - 2025)
Oramed Pharmaceuticals' Return on Sales [ROS] was -754.40% in Q4 2025, down 103.85 percentage points from the prior quarter.
Powered by 
Analysis
Oramed Pharmaceuticals (ORMP) Return on Sales [ROS] (2016 - 2025) Analysis & Trends
From Q2 2016 onward, Oramed Pharmaceuticals has reported Return on Sales [ROS] for 28 quarters.
- Return on Sales [ROS] shows a four-year change of +141.75 percentage points (FY2021 to FY2025).
- In earlier years, Return on Sales [ROS] was -1176.79% in FY2023 (+325.17 pp), -1501.96% in FY2022 and -896.15% in FY2021.
- The Q4 2025 figure marks the lowest quarterly Return on Sales [ROS] since Q4 2023.
- Per Business Quant data, ORMP's Return on Sales [ROS] in the three quarters before Q4 2025 was -650.55% (Q3 2025), -683.65% (Q2 2025) and -225.00% (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 28.37% |
| 10 | Oramed Pharmaceuticals | 185.50 Mn | 185.50 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -754.40% |
| Sep 30, 2025 | -650.55% |
| Jun 30, 2025 | -683.65% |
| Mar 31, 2025 | -225.00% |
| Dec 31, 2023 | -1,176.79% |
| Sep 30, 2023 | -1,079.23% |
| Jun 30, 2023 | -562.46% |
| Mar 31, 2023 | -781.98% |
| Dec 31, 2022 | -1,363.50% |
| Sep 30, 2022 | -1,200.73% |
| Jun 30, 2022 | -1,693.92% |
| Mar 31, 2022 | -1,689.49% |
| Nov 30, 2019 | -360.39% |
| Aug 31, 2019 | -344.35% |
| May 31, 2019 | -597.95% |
| Feb 28, 2019 | -535.74% |
| Nov 30, 2018 | -688.43% |
| Aug 31, 2018 | -510.53% |
| May 31, 2018 | -734.85% |
| Feb 28, 2018 | -515.07% |
API Access
Oramed Pharmaceuticals Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ORMP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "ORMP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ORMP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();